awmsg logo



bosentan (Tracleer®)


Reference No. 68

Publication date:
07/09/2011


Appraisal information

bosentan (Tracleer®) 62.5 mg film-coated tablet
bosentan (Tracleer®) 125 mg film-coated tablet


Company: Actelion Pharmaceuticals UK Ltd
BNF category: Cardiovascular system
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 01/09/2011

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, bosentan (Tracleer®) cannot be endorsed for use within NHS Wales for the treatment of class II pulmonary arterial hypertension (license extension).
Statement of Advice (SOA)
Download